Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Well, FBG, tell me why institutional investors are supposed to worry about the company--which is progressing fantastically in its vaccine development on a dozen fronts--simply because ADXS raised capital and issued a few hundred thousand options. What fundamental analysis are they going through that says, you know, those things make this company, with its amazing platform, alot more risky? Answer: they don't care. And if the stock was trading at 20 right now, neither would you. You seem to have arrived at the conclusion that management controls the share price of a stock which, in reality, is in a beaten down sector, and is a stock that has been incessantly manipulated and attacked since the Pearson smear two years ago. Has nothing to do with management, which is producing on substance. The other stuff about management options, and RSUs granted in 2014, is irrelevant fluff.